CAS 1092942-82-9

Formula: C29H31N7O

InChI: InChI=1S/C29H31N7O/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34)/i14D2,15D2,16D2,17D2

InChI key: KTUFNOKKBVMGRW-AZGHYOHESA-N

SMILES: [2H]C1(C(N(C(C(N1C)([2H])[2H])([2H])[2H])CC2=CC=C(C=C2)C(=O)NC3=CC(=C(C=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5)([2H])[2H])[2H]

Imatinib-d8

CAS: 1092942-82-9

Imatinib-d8

Formula: C₂₉H₂₃D₈N₇O

Purity: ≥98 atom% D,≥98%

Molecular weight: 501.65

Ref: 54-DE2909

Imatinib-d8

CAS: 1092942-82-9

Formula: C₂₉H₂₃D₈N₇O

Color and Shape: White To Off-White Solid

Molecular weight: 501.66

Ref: 4Z-I-092

Imatinib-D8

CAS: 1092942-82-9

Imatinib-d8 (STI571 D8) is a 2H-labeled form of Imatinib. Imatinib is a multi-target receptor tyrosine kinase inhibitor with antitumor activity.

Formula: C₂₉H₂₃D₈N₇O

Purity: 98%

Color and Shape: Solid

Molecular weight: 501.65

Ref: TM-T11640

Imatinib-d8

Controlled Product

CAS: 1092942-82-9

Applications Imatinib-d8 is a deuterated tyrosine kinase inhibitor. It is a COVID19-related research product.
References Schindler, T., et al.: Science, 289, 1938 (2000); Drucker, B.J., et al.: N. Engl. J. Med., 344, 1031 (2001)

Formula: C₂₉₂H₈H₂₃N₇O

Color and Shape: Neat

Molecular weight: 501.65

Ref: TR-I267987

Iguratimod Impurity 40 HCl

CAS: 1092942-82-9

Formula: C₁₄H₁₃NO₃HCl

Color and Shape: White To Off-White Solid

Molecular weight: 243.26 36.46

Ref: 4Z-I-092042

Imatinib-[d8]

CAS: 1092942-82-9

Formula: C₂₉H₃₁N₇O

Molecular weight: 501.7

Ref: BE-MD-7250D8

Imatinib-d8

CAS: 1092942-82-9

Formula: C₂₉H₃₁N₇O

Molecular weight: 501.7

Ref: BE-RMCI030011